XML 43 R27.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Derivatives and Hedging | 12 Months Ended
--- | ---
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivatives and Hedging | Derivatives and Hedging The following table summarizes the fair value of our derivative instruments as well as the location of the asset and/or liability on the consolidated balance sheets as of the periods presented below (in millions):
|  |  | Fair Value of Asset Derivatives
|  |  | December 31,
| Balance Sheet Location |  | 2024 |  | 2023
Derivatives designated as cash flow hedging instruments: |  |  |  |  |
Foreign currency forward contracts | Other current assets |  | $ | 0.1 |  |  | $ | — |
Interest rate swap contracts | Other current assets |  | 3.0 |  |  | 5.2 |
Interest rate swap contracts | Other assets, net |  | 4.8 |  |  | — |
Total |  | $ | 7.9 |  |  | $ | 5.2 |
Derivatives not designated as hedging instruments: |  |  |  |  |
Foreign currency forward contracts | Other current assets |  | 5.6 |  |  | 0.2 |
Total asset position |  | $ | 13.5 |  |  | $ | 5.4 |
|  |  | Fair Value of Liability Derivatives
|  |  | December 31,
| Balance Sheet Location |  | 2024 |  | 2023
Derivatives designated as cash flow hedging instruments: |  |  |  |  |
Foreign currency forward contracts | Accounts payable and accrued expenses |  | $ | 0.8 |  |  | $ | — |
Interest rate swap contracts | Other long-term liabilities |  | — |  |  | 2.6 |
|  |  | 0.8 |  |  | 2.6 |
Derivatives not designated as hedging instruments: |  |  |  |  |
Foreign currency forward contracts | Accounts payable and accrued expenses |  | 0.2 |  |  | 4.5 |
Total liability position |  | $ | 1.0 |  |  | $ | 7.1 |
Our derivative instruments are subject to a master netting agreement with each respective counterparty bank and are therefore net settled at their respective maturity date. Although we have the legal right of offset under the master netting agreements, we have elected to present these contracts on a gross basis on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. Gains and losses related to our derivative instruments are presented as an adjustment to reconcile net income to net cash provided by or used in operating activities in the consolidated statements of cash flows. Cash Flow Hedging Instruments Foreign Currency Forward Contracts As of December 31, 2024, the notional amounts of our foreign currency forward contracts designated as cash flow hedging instruments was a short position of approximately $9.4 million. As of December 31, 2023, there were no notional amounts on our foreign currency contracts designated as cash flow hedging instruments. During the year ended December 31, 2024, we recorded net gains of $4.9 million in accumulated other comprehensive loss related to foreign currency forward contracts, and released net gains of $5.9 million in cost of products for the underlying sales that were recognized. Additionally, for the year ended December 31, 2024, $2.8 million of net gains related to the amortization of forward points were released from other comprehensive income and recognized in cost of products. Based on the current valuation, we expect to reclassify net losses of $0.7 million related to foreign currency forward contracts from accumulated other comprehensive income into earnings during the next 12 months. For the years ended December 31, 2023 and 2022, we recognized net gains of $8.6 million and $2.0 million in accumulated other comprehensive loss related to forward currency forward contracts. For the years ended December 31, 2023 and 2022, we released net gains of $5.9 million and $4.8 million, respectively, into cost of products related to foreign currency forward contracts. Interest Rate Swap Contracts We used interest rate swaps in order to mitigate the risk of changes in interest rates associated with our variable-rate long term debt. As a part of our debt modification in March 2023 (see Note 7), we entered into a termination agreement to unwind an existing interest rate swap, and as a result, we received proceeds of $5.6 million. As of December 31, 2024 and 2023, $0.2 million and $3.2 million were included in accumulated other comprehensive loss related to these proceeds, respectively, and will be amortized into interest expense over the remaining term of the contract. In April 2023, we entered into interest rate swaps designated as cash flow hedges in order to mitigate the risk of interest rate fluctuations associated with our 2023 Term Loan B as well as any of our other variable rate debt. Over the life of the 2023 Term Loan B, we will receive variable interest payments from the counterparty lenders in exchange for fixed interest rate payments, which are made at a weighted-average rate of 3.36% across our interest rate swap contracts without exchange of the underlying notional amount, which was $400.0 million as of December 31, 2024 and 2023, respectively. The following tables summarize the net effect of all cash flow hedges on the consolidated financial statements for the periods presented (in millions):
|  | Gain Recognized in Other Comprehensive Income
|  | Year Ended December 31,
Derivatives designated as cash flow hedging instruments |  | 2024 |  | 2023 |  | 2022
Foreign currency forward contracts |  | $ | 4.9 |  |  | $ | 8.6 |  |  | $ | 2.0 |
Interest rate swap contracts |  | 12.6 |  |  | 6.9 |  |  | 14.2 |
Total |  | $ | 17.5 |  |  | $ | 15.5 |  |  | $ | 16.2 |
|  | Gain (Loss) Reclassified from Other Comprehensive Income into Earnings
|  | Year Ended December 31,
Derivatives designated as cash flow hedging instruments |  | 2024 |  | 2023 |  | 2022
Foreign currency forward contracts |  | $ | 5.9 |  |  | $ | 5.9 |  |  | $ | 4.8 |
Interest rate swap contracts |  | 10.3 |  |  | 8.2 |  |  | (1.6) |
Total |  | $ | 16.2 |  |  | $ | 14.1 |  |  | $ | 3.2 |
Based on the current valuation as of December 31, 2024, we expect to reclassify a net gain of $7.8 million related to the interest rate swap contracts from accumulated other comprehensive loss into earnings during the next 12 months. Foreign Currency Forward Contracts Not Designated as Hedging Instruments We use foreign currency forward contracts that are not designated as qualifying cash flow hedging instruments to mitigate our exposure to fluctuations in foreign currency exchange rates due to the remeasurement of certain balance sheet payables and receivables denominated in foreign currencies, as well as gains and losses resulting from the translation of the operating results of our international subsidiaries into U.S. dollars for financial reporting purposes. These contracts generally mature within 12 months from inception. As of December 31, 2024, 2023 and 2022, the notional amounts of our foreign currency forward contracts used to mitigate the exposures discussed above were approximately $203.0 million, $209.4 million, and $162.9 million, respectively. We estimate the fair values of foreign currency forward contracts based on pricing models using current market rates, and record all derivatives on our consolidated balance sheet at fair value, with changes in fair value recorded in our consolidated statements of operations. Foreign currency forward contracts are classified under Level 2 of the fair value hierarchy (see Note 17). The following table summarizes the location of net gains and losses for each type of our derivative contracts recognized in the consolidated statements of operations for the periods presented (in millions):
|  |  |  | Amount of Net Gain Recognized in Income on Derivative Instruments
Derivatives not designated as hedging instruments |  | Location of Net Gain Recognized in Income on Derivative Instruments |  | Years Ended December 31,
|  | 2024 |  | 2023 |  | 2022
Foreign currency forward contracts |  | Other income, net |  | $ | 31.9 |  |  | $ | 19.6 |  |  | $ | 44.5 |
During the years ended December 31, 2024, 2023 and 2022, we recognized net foreign currency transactional losses of $22.3 million, $6.4 million and $18.3 million, respectively, in our consolidated statements of operations.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5C -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/815/tableOfContent + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration